UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.
Wiad Lek. 2023;76(11):2395-2400. doi: 10.36740/WLek202311109.
The aim: To study the peculiarities of diabetic polyneuropathy in patients with type 2 diabetes mellitus and concomitant NAFLD.
Materials and methods: We examined 75 patients with type 2 diabetes mellitus, including 31 (41.3%) women and 44 (58.7%) men. The main group included 35 patients with NAFLD (46.7%), and the control group included 40 patients without NAFLD (53.3%). The severity of polyneuropathy was assessed using the Toronto clinical neuropathy score. The presence of neuropathic pain syndrome in patients allowed us to divide patients into groups with painful or painless forms of diabetic polyneuropathy. The electroneuromyographic examination was used to study nerve conduction parameters, namely peroneal motor nerve conduction velocity (PMNCV), sensory nerve action potential (SNAP), and sensory nerve conduction velocity (SNCV).
Results: The proportion of patients who did not have diabetic polyneuropathy in the NAFLD group was 12.5%, and in the group without NAFLD - 87.2%. The frequency of diabetic polyneuropathy was higher in the main group, namely: mild, moderate, and severe polyneuropathy was 80%, 56% and 59.3%, respectively, compared to the control group - 20%, 44%, 40.7% (p=0.02). The painful form of DPN was more common in patients of the main group than in the control group, respectively 69.8% and 30.2% (p=0.01). The degree of liver fibrosis did not affect the course of DPN. The study of nerve conduction by PMNCV, SNAP, and SNCV parameters showed that PMNCV was higher in the NAFLD group, and SNAP and SNCV - in the control group, but without statistical significance (p>0.05).
Conclusions: In patients with type 2 diabetes mellitus, the presence of NAFLD affects the severity of diabetic polyneuropathy and increases the risk of painful DPN. The degree of liver fibrosis did not show an effect on the development of diabetic polyneuropathy. ENMG parameters did not demonstrate a statistically significant difference in the study groups.
研究 2 型糖尿病伴非酒精性脂肪性肝病(NAFLD)患者糖尿病多发性神经病的特点。
我们检查了 75 例 2 型糖尿病患者,包括 31 例(41.3%)女性和 44 例(58.7%)男性。主要组包括 35 例 NAFLD 患者(46.7%),对照组包括 40 例无 NAFLD 患者(53.3%)。使用多伦多临床神经病评分评估多发性神经病的严重程度。患者中存在神经痛综合征使我们能够将患者分为伴有疼痛或无痛形式的糖尿病多发性神经病组。使用神经电生理检查研究神经传导参数,即腓总运动神经传导速度(PMNCV)、感觉神经动作电位(SNAP)和感觉神经传导速度(SNCV)。
NAFLD 组无糖尿病多发性神经病患者的比例为 12.5%,无 NAFLD 组为 87.2%。主要组中糖尿病多发性神经病的频率更高,即:轻度、中度和重度多发性神经病分别为 80%、56%和 59.3%,而对照组分别为 20%、44%和 40.7%(p=0.02)。主要组中 DPN 的疼痛形式比对照组更常见,分别为 69.8%和 30.2%(p=0.01)。肝纤维化程度不影响 DPN 的病程。PMNCV、SNAP 和 SNCV 参数的神经传导研究表明,NAFLD 组的 PMNCV 较高,而对照组的 SNAP 和 SNCV 较高,但无统计学意义(p>0.05)。
在 2 型糖尿病患者中,NAFLD 的存在影响糖尿病多发性神经病的严重程度,并增加疼痛性 DPN 的风险。肝纤维化程度对糖尿病多发性神经病的发展没有影响。EMG 参数在研究组中没有表现出统计学上的显著差异。